Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs

The Trump administration has introduced a rule that aims to prevent hospitals from inflating the prices of discounted drugs for Medicare patients, potentially saving them $1.1 billion. This move targets the practice of hospitals buying discounted drugs from manufacturers and then selling them at higher rates to Medicare patients. The proposal is significant because it tackles a long-standing issue in the healthcare system that has left many seniors paying more than they should for their medications. The change could lead to more affordable healthcare options for Medicare recipients and could set a precedent for broader drug pricing reforms.